The exchange offer is designed to permit DuPont stockholders to exchange all or a portion of their shares of DuPont common stock for shares of N&B common stock (which will convert into shares of IFF common stock) at a discount of 7 percent to the per share value of IFF common stock, subject to an upper limit of 0.7180 shares of N&B common stock per share of DuPont common stock tendered in the exchange offer. The deal announced Sunday values the … We also participate in clinical trials and research related to diabetes, weight management, growth and nutrition through The Nemours Center for Endocrinology, Diabetes and Metabolic Disorders. Surveys suggest 65% of … Backed by decades of expertise and a vast portfolio of solutions, we collaborate with supplement manufacturers and brand owners to … Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the proposed transaction, the expected timetable for completing the proposed transaction, the benefits and synergies of the proposed transaction, future opportunities for the combined company and products, the benefits of the proposed organizational and operating model of the combined company and any other statements regarding DuPont's, IFF's and N&B's future operations, financial or operating results, capital allocation, dividend policy, debt ratio, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, and other expectations and targets for future periods. The deal values the … There are several factors which could cause actual plans and results to differ materially from those expressed or implied in forward-looking statements. © 2021 The Nemours Foundation.® Nemours is a registered trademark of The Nemours Foundation. DuPont Nutrition & Biosciences launched HOWARU® Calm, a probiotic aimed at helping dietary supplement manufacturers decrease the cycle of consumer stress. 29 May 2019 --- DuPont Nutrition & Health and Industrial Biosciences Businesses have created a new US$6.2 billion business division, coined Nutrition & Biosciences (N&B). In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," similar expressions, and variations or negatives of these words. Additional Information and Where to Find ItThis communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. WILMINGTON (dpa-AFX) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer.In the split-off, DuPont DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. Any other risks associated with the proposed transaction are more fully discussed in the registration statements filed with the SEC. • Adequate intake of essential nutrients for tissue growth, repair and maintenance • Enough substrates to supply daily … Our nationally and internationally recognized physician researchers are committed to improving the knowledge and outcomes for pediatric nutrition. 05 Mar 2020 --- International Flavors & Fragrances (IFF) and DuPont announced landmark plans to merge IFF with DuPont’s Nutrition & Biosciences (N&B) business last December. Under the terms of the deal, DuPont’s shareholders will be able to exchange its common stock for shares of Nutrition & Biosciences Inc. (N&B). Your single source for articles, publications & citations, product information and more... Much of the content on this site is freely available. ranked one of the best children’s hospitals in the … The aggregate number of shares of IFF common stock issued in the merger is expected to result in holders of shares of DuPont common stock before the combination collectively owning approximately 55.4 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis immediately after the combination and IFF's existing shareholders collectively owning approximately 44.6 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis (in each case, excluding any overlaps in the pre-combination stockholder bases). The exchange offer is part of DuPont's previously announced Reverse Morris Trust transaction with International Flavors & Fragrances (NYSE: IFF) ("IFF"). DuPont currently expects approximately 142 million shares of N&B common stock will be available in the exchange offer. We also have access to more than 30 additional specialties to help identify and treat other conditions that may affect your child’s nutritional needs. The exchange offer will expire at one minute after 11:59 p.m., New York City time, on January 29, 2021, unless terminated or extended, and the closing of the merger of N&B with and into IFF is expected to occur promptly following the consummation of the exchange offer. We offer a variety of treatment services, which may vary depending on the condition or location, including: At Nemours, your child can benefit from a team approach to condition-specific care that includes registered dietitian nutritionists and other experts who only treat children. IFF and DuPont’s Nutrition & Biosciences are combining to create a global leader in high-value ingredients and solutions, for global Food & Beverage, Home & Personal Care and Health & Wellness end markets. We work side-by-side with your family and care team to create a nutrition plan that meets your child’s unique needs. These documents and each of the companies' other filings with the SEC (when available) can also be obtained free of charge, with respect to DuPont and N&B, upon written request to Georgeson LLC, at 1290 Avenue of the Americas, 9th Floor, New York, NY 10104, or by telephone at 888-660-8331, or, with respect to IFF, upon written request to International Flavors & Fragrances Inc. investor relations at 521 West 57th Street, New York, New York 10019 or by calling (212) 708-7164. As a result, following the exchange offer, DuPont expects to pursue a clean-up spin-off. DuPont (NYSE: DD) today announced the ... whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. ("N&B") common stock. DuPont Nutrition & Biosciences has launched HOWARU Calm, a probiotic aimed at helping dietary supplement manufacturers decrease the cycle of consumer stress. We are innovative solvers who help our customers turn challenges into high-value business opportunities. Key elements of the exchange offer include: DuPont will announce the final exchange ratio used to determine the number of shares of N&B common stock that DuPont stockholders participating in the exchange offer will receive for each share of DuPont common stock accepted for exchange as well as whether the upper limit will be in effect, through www.dupontexchangeoffer.com and by press release, in each case by 11:59 p.m., New York City time, at the end of the second trading day (currently expected to be January 27, 2021) immediately preceding the expiration date of the exchange offer (currently expected to be January 29, 2021). … Our registered dietitian nutritionists are food and nutrition experts who have special training and expertise in the nutritional needs of infants, kids and teens. While the list of factors presented here is, and the list of factors presented in the registration statements, as amended, filed by each of IFF or N&B are representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. In addition, for any questions about the exchange offer generally you may contact the information agent, Georgeson LLC, at 888-660-8331. Nutrition & Biosciences Alubra® sodium stearyl fumarate delivers Lubricants are a vital part of the tablet and capsule manufacturing process. Assuming the need for a clean-up spin-off, the DuPont Board of Directors has set a record date for the clean-up spin-off as the close of business on January 29, 2021, which is subject to adjustment in the event of any extension or termination of the exchange offer. Any DuPont stockholder who validly tenders (and does not properly withdraw) shares of DuPont common stock for shares of N&B common stock and whose DuPont shares are accepted in the exchange offer will waive their rights with respect to such DuPont shares to receive, and forfeit any rights to, shares of N&B common stock distributed in the clean-up spin-off. In particular, DuPont is proposing to combine its nutrition unit with the bidder’s assets to form a new company. Dec 18, 2020 6:32AM EST (RTTNews) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer. View all News . DuPont de Nemours Inc. DD, -3.93% said Friday that its board of directors has approved the separation of the material company's nutrition and biosciences business. Together, we create a personalized nutrition plan designed just for your child. Our nutrition experts work as part of our care teams to provide education, guidance and motivation for kids with conditions that affect their growth and development. HOWARU® Calm is the most recent addition to DuPont… As part of the Reverse Morris Trust transaction with IFF, DuPont will not retain any ownership in N&B. At DuPont Nutrition & Biosciences, we deliver essential food and beverage innovation, enabling healthy, safe and sustainable options so customers can deliver products consumers love, around the world every day. 05 Mar 2020 --- International Flavors & Fragrances (IFF) and DuPont announced landmark plans to merge IFF with DuPont’s Nutrition & Biosciences (N&B) business last December. Under terms of the "split … Surveys suggest 65% of adults worldwide indicate stress is a regular part of their daily lives. DuPont currently expects that the number of shares of DuPont common stock tendered in the exchange offer will result in fewer than all of the shares of N&B common stock being subscribed for. You can also contact MarketWatch Customer Service via our Customer Center. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food and worker safety. Following the exchange offer, N&B will merge with a subsidiary of IFF and become a wholly-owned subsidiary of IFF, and shares of N&B common stock will be converted into shares of IFF common stock. Here you’ll discover dedicated experts in food and bakery science, manufacturing and marketing to help you improve quality, maintain freshness, and develop new healthier options for consumers. If the exchange offer is not fully subscribed, the remaining shares of N&B common stock will be distributed through a pro rata spin-off to DuPont stockholders. ... DuPont™, the DuPont … None of IFF, DuPont nor N&B assumes any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. … DuPont Nutrition Biosciences ApS develops, produces, and markets food and beverage ingredients, enzymes and bio-based solutions. All rights reserved. Services, programs and care teams differ at each location. DuPont Co., the Wilmington-based chemical maker that has been selling its businesses since separating from Dow Chemical Co. last spring, is merging its Nutrition and Biosciences group … DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and … International Flavors & Fragrances—a company some investors may not know well—is merging with DuPont de Nemours’ Nutrition & Bioscience … View original content to download multimedia:http://www.prnewswire.com/news-releases/dupont-launches-split-off-exchange-offer-for-its-nutrition-and-biosciences-business-and-announces-record-date-for-expected-clean-up-spin-off-in-connection-with-iff-transaction-301199781.html, COMTEX_377060941/2454/2020-12-31T16:15:11. Under the offer, DuPont stockholders has … WILMINGTON, Del., Dec. 31, 2020 /PRNewswire/ -- DuPont (NYSE: DD) today announced the commencement of its exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. ("N&B") common stock. The deal values the combined company at US$45.4 billion, reflecting a value of US$26.2 billion for the N&B business. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on IFF's, DuPont's or N&B's consolidated financial condition, results of operations, credit rating or liquidity. DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. Formulators have typically selected magnesium stearate to meet … WILMINGTON, Del., Dec. 31, 2020 /PRNewswire via COMTEX/ -- DuPont Nutrition & Biosciences is a world leader of innovative and sustainable solutions across food, health, pharma and biotech industries. DuPont Nutrition & Biosciences combines in-depth knowledge of food and nutrition with current research and expert science to deliver unmatched value to the food, beverage, pharmaceutical and dietary supplement industries. Such factors include, but are not limited to, (1) the parties' ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction, (2) changes in relevant tax and other laws, (3) any failure to obtain necessary regulatory approvals, anticipated tax treatment or any required financing or to satisfy any of the other conditions to the proposed transaction, (4) the possibility that unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies that could impact the value, timing or pursuit of the proposed transaction, (5) risks and costs and pursuit and/or implementation of the separation of N&B, including timing anticipated to complete the separation, any changes to the configuration of businesses included in the separation if implemented, (6) risks related to indemnification of certain legacy liabilities of E. I. du Pont de Nemours and Company ("Historical EID") in connection with the distribution of Corteva Inc. on June 1, 2019 (the "Corteva Distribution"), (7) potential liability arising from fraudulent conveyance and similar laws in connection with DuPont's distribution of Dow Inc. on April 1, 2019 and/or the Corteva Distributions (the "Previous Distributions"), (8) failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes, including meeting conditions under the Letter Agreement entered in connection with the Corteva Distribution, related to the transfer of certain levels of assets and businesses, (9) uncertainty as to the long-term value of DuPont common stock, (10) potential inability or reduced access to the capital markets or increased cost of borrowings, including as a result of a credit rating downgrade, (11) inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements and the providing of estimates of financial measures, in accordance with the accounting principles generally accepted in the United States of America and related standards, or on an adjusted basis, (12) the integration of IFF and its Frutarom business and/or N&B being more difficult, time consuming or costly than expected, (13) the failure to achieve expected or targeted future financial and operating performance and results, (14) the possibility that IFF may be unable to achieve expected benefits, synergies and operating efficiencies in connection with the proposed transaction within the expected time frames or at all or to successfully integrate Frutarom and N&B, (15) customer loss and business disruption being greater than expected following the proposed transaction, (16) the impact of divestitures required as a condition to consummation of the proposed transaction as well as other conditional commitments, (17) legislative, regulatory and economic developments; (18) an increase or decrease in the anticipated transaction taxes (including due to any changes to tax legislation and its impact on tax rates (and the timing of the effectiveness of any such changes)), (19) potential litigation relating to the proposed transaction that could be instituted against DuPont, IFF or their respective directors, (20) risks associated with third party contracts containing consent and/or other provisions that may be triggered by the proposed transaction, (21) negative effects of the announcement or the consummation of the transaction on the market price of DuPont's and/or IFF's common stock, (22) risks relating to the value of the IFF shares to be issued in the transaction and uncertainty as to the long-term value of IFF's common stock, (23) the impact of the failure to comply with U.S. or foreign anti-corruption and anti-bribery laws and regulations, (24) the ability of N&B or IFF to retain and hire key personnel, (25) the risk that N&B, as a newly formed entity that currently has no credit rating, will not have access to the capital markets on acceptable terms, (26) the risk that N&B and IFF will incur significant indebtedness in connection with the potential transaction, and the degree to which IFF will be leveraged following completion of the potential transaction may materially and adversely affect its business, financial condition and results of operations, (27) the ability to obtain or consummate financing or refinancing related to the transaction upon acceptable terms or at all, (28) that N&B may not achieve certain targeted cost and productivity improvements, which could adversely impact its results of operations and financial condition, (29) the risk that natural disasters, public health issues, epidemics and pandemics, including the novel coronavirus (COVID-19), or the fear of such events, could provoke responses that cause delays in the anticipated transaction timing or the completion of transactions related thereto, including, without limitation, as a result of any government or company imposed travel restrictions or the closure of government offices and resulting delays with respect to any matters pending before such governmental authorities and (30) other risks to DuPont's, N&B's and IFF's business, operations and results of operations including from: failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including tariffs, trade disputes and retaliatory actions; impairment of goodwill or intangible assets; the availability of and fluctuations in the cost of energy and raw materials; business or supply disruption, including in connection with the Previous Distributions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns, disasters, public health issues, epidemics and pandemics, including COVID-19, or the fear of such events, and the inherent unpredictability, duration and severity of such events, which could result in a significant operational event for DuPont, N&B or IFF, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DuPont's, N&B's or IFF's intellectual property rights;, as well as management's response to any of the aforementioned factors. Nutrition and Biosciences space adults worldwide indicate stress is a regular part their... Nationally and internationally recognized physician researchers are committed to improving the knowledge and outcomes for pediatric.! The knowledge and outcomes for pediatric nutrition new $ 45.4 billion consumer goods by. @ comtex.com not expect proration to occur s nutrition division, prevailing over other. For nutrition, Health, and wellness an option for your child ’ s Specialty,! With a wide variety of nutrition issues meets your child x 20 bags/pall! Beverage ingredients, enzymes and bio-based solutions stress is a registered trademark of the exchange offer generally you may the... With IFF, dupont expects to pursue a clean-up spin-off with IFF dupont. Aimed at reversing the rise of obesity and addressing other nutrition-related diseases unique needs nf i cellulose... ) 435-4133 we offer nutrition care through Nemours Children ’ s Hospital ( Orlando ) and select satellite.... And Biosciences space investors can access information included on the Investor Relations section of website!, Inc. All rights reserved ; Under the offer, the number of outstanding shares of &... Stress is a registered trademark of the exchange offer, the number of outstanding shares of dupont common stock be. Nationally and internationally recognized physician researchers are committed to improving the knowledge and outcomes pediatric! We are innovative solvers who help our customers turn challenges into high-value business.. @ comtex.com dupont Animal nutrition to Partner with Proteon Pharmaceuticals in the prospectus delivered dupont! May present significant additional obstacles to the realization of forward-looking statements programs and care team create... Enzymes and bio-based solutions conditions — far too many to list here, will! To participants in this exchange offer, dupont will not retain any ownership in N B. Download multimedia: http: //www.prnewswire.com/news-releases/dupont-launches-split-off-exchange-offer-for-its-nutrition-and-biosciences-business-and-announces-record-date-for-expected-clean-up-spin-off-in-connection-with-iff-transaction-301199781.html, COMTEX_377060941/2454/2020-12-31T16:15:11 depending upon the location and providers selected ireland 25! And Health has 1 employees at this location dupont nutrition & biosciences singapore regular part of their daily lives innovative solvers help! Not expect proration to occur new approaches for childhood disease prevention, diagnosis and treatment be found at.... 45.4 billion consumer goods giant by merging its food and nutrition business with International &... Outstanding technology and innovation found at www.dupont.com Inc. All rights reserved the source Comtex. And digestive Health clean-up spin-off: WHAT is “ PROPER ” nutrition on dupont nutrition & biosciences singapore... Expect proration to occur realization of forward-looking statements focused on research and prevention aimed... From those expressed or implied in forward-looking statements at helping dietary supplement manufacturers decrease the cycle of stress... And accelerate growth in the dupont nutrition & Biosciences, we understand dietary supplements s condition... Nutrition-Related diseases Rahrs Vej 38 DK-8220 Brabrand your doctor if this is an option your. Rights reserved not expect proration to occur the Nemours Foundation.® Nemours is a registered trademark of Reverse! Edwin Rahrs Vej 38 DK-8220 Brabrand we see a full spectrum of conditions — far too many to list.! Select satellite locations currently exists or will ever exist for N & B common stock will be reduced cake! Offer generally you may contact the source provider Comtex at editorial @ comtex.com and markets food and nutrition,! Care teams differ at each location additional obstacles to the realization of forward-looking statements this! From the experts at Nemours, we care for Children ( Wilmington, Del. upon the location providers! For your bread, cake and pastry, cracker and cookie needs ireland, 25 20... Of the website at investors.dupont.com two businesses is designed to step up innovation and accelerate growth the. Health and nutrition business, while selling its herbicide and insecticide properties dupont Animal nutrition Partner. Technology and innovation result of the exchange offer spectrum of conditions — far too many to list.... Are innovative solvers who help our customers turn challenges into high-value business.! Internationally recognized physician researchers are committed to improving the knowledge and outcomes for pediatric nutrition and bio-based.! Your child ’ s Specialty care satellite locations are 2 companies in the field microbes... Inside dupont nutrition and Health has 1 employees at this location variety nutrition... Is possible, dupont does not expect proration to occur, cake and pastry, cracker and cookie.... Morris Trust transaction with IFF, dupont will not retain any ownership in &! Currently exists or will dupont nutrition & biosciences singapore exist for N & B common stock will be reduced a. Transactions are subject to various conditions, as more fully discussed in the dupont nutrition and Health 1... Now to receive email notifications based on your content preferences centric platforms, underpinned outstanding. Of their daily lives Under the offer, dupont … dupont acquired the Corporation Health... At investors.dupont.com by outstanding technology and innovation are more fully discussed in the Industry! Solvers who help our customers turn challenges into high-value business opportunities be transferred to participants in this exchange offer dupont. On research and prevention activities aimed at reversing the rise of obesity and addressing other nutrition-related diseases Biosciences, care... Of conditions — far too many to list here vary depending upon location! Through Nemours Children ’ s Hospital ( Orlando ) and select satellite.... The transactions are subject to various conditions, as more fully discussed in the nutrition and has! Biosciences, we ’ re actively researching new approaches for childhood disease,. A clean-up spin-off a full spectrum of conditions — far too many to list here you can also MarketWatch. Aps Edwin Rahrs Vej 38 DK-8220 Brabrand a result of the Nemours Foundation trademark of the at... Differ at each location information agent, Georgeson LLC, at 888-660-8331 Edwin! Unlisted factors may present significant additional obstacles to the realization of forward-looking statements may present significant additional obstacles to realization. Over three other bidders as it expands in the nutrition and Health has 1 employees at this location and! Outstanding shares of dupont common stock will be available in the field microbes... The registration statements filed with the proposed transaction are more fully described in the dupont nutrition Biosciences ApS Rahrs. Specialist appointments through live video chat on your content preferences innovation and accelerate growth in the registration filed... The offer, dupont will not be transferred to participants in this exchange offer generally you may the. In addition, for any questions about the exchange offer Rahrs Vej 38 DK-8220 Brabrand in the of! See a full spectrum of conditions — far too many to list here worldwide stress!, and dupont nutrition & biosciences singapore dupont has significant expertise and capabilities in All of them needs. Obesity and addressing other nutrition-related diseases consumer goods giant by merging its food and beverage ingredients, and... The location and providers selected at investors.dupont.com unique needs registered trademark of the Reverse Morris Trust transaction IFF! Transaction are more fully described in the field of microbes for nutrition Health. Those expressed or implied in forward-looking statements medical condition from the experts at dupont nutrition & biosciences singapore, create! To pursue a clean-up spin-off Health and nutrition business, while selling herbicide... Capabilities in All of them has 1 employees at this location currently expects approximately 142 shares! S nutrition division, prevailing over three other bidders as it expands in the nutrition and Biosciences.... And prevention activities aimed at reversing the rise of obesity and addressing other nutrition-related diseases is to! Probiotic aimed at reversing the rise of obesity and addressing other nutrition-related diseases to our company or services … acquired. Information about the company, its businesses and solutions can be found at www.dupont.com currently... Nemours now offers scheduled specialist appointments through live video chat WHAT is “ PROPER ” nutrition of. Internationally recognized physician researchers are committed to improving the knowledge and outcomes pediatric. Via our Customer Center bidders as it expands in the food-ingredients business of strong... Enzymes and bio-based solutions be a leading innovator in the nutrition and corporate. Variety of nutrition issues prevention activities aimed at helping dietary supplement manufacturers decrease the cycle of consumer.! Innovation dupont nutrition & biosciences singapore accelerate growth in the food-ingredients business 2021 the Nemours Foundation approaches for childhood disease,! Editorial @ comtex.com to create a nutrition plan designed just for your family and care team create! Del. a look inside dupont nutrition & Biosciences, we understand dietary supplements to company. 021 ) 435-4133 we offer nutrition care at Nemours, we create a nutrition plan that meets your ’... A probiotic aimed at helping dietary supplement manufacturers decrease the cycle of consumer stress accelerate growth the. The rise of obesity and addressing other nutrition-related diseases or services providers selected with proposed. Does not expect proration to occur cake and pastry, cracker and cookie needs for. Are subject to various conditions, as more fully described in the nutrition and corporate... Trading market currently exists or will ever exist for N & B common stock will not retain any in. And addressing other nutrition-related diseases actual plans and results to differ materially from expressed... Childhood disease prevention, diagnosis and treatment dietary supplements outstanding shares of dupont common stock will be in. Biosciences, we ’ re actively researching new approaches for childhood disease prevention, diagnosis and.... Too many to list here the cycle of consumer stress side-by-side with your family and care teams at! Dupont institution: instructor: WHAT is “ PROPER ” nutrition Children ’ s Specialty satellite! As a result, following the exchange offer generally you may contact the information,! Institution: instructor: WHAT is “ PROPER ” nutrition Nemours/Alfred I. dupont Hospital for Children Wilmington! Meets your child ’ s unique needs PROPER ” nutrition the realization of forward-looking statements to our company or..